Stock listing
VTGN Stock Price, News, Filings & Events — Vistagen Therapeutics, Inc.
Selected listing: VTGN · NASDAQ · USD · US
This page tracks Vistagen Therapeutics, Inc.'s VTGN:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VTGN:NASDAQ. VTGN:NASDAQ is the stock-level entry point for investors researching Vistagen Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Vistagen Therapeutics, Inc. (ticker: VTGN) is a public company based in the United States, focusing on developing treatments for mental health conditions. The company has a market capitalization of approximately $9.29 million. Vistagen is dedicated to advancing its innovative therapies to address unmet needs in the mental health space.
- Ticker
- VTGN:NASDAQ
- Asset type
- Stock
- Market cap
- $10.5M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Vistagen Therapeutics, Inc. VTGN:NASDAQ stock context
This page tracks Vistagen Therapeutics, Inc.'s VTGN:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VTGN:NASDAQ. VTGN:NASDAQ is the stock-level entry point for investors researching Vistagen Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Vistagen Therapeutics, Inc. (ticker: VTGN) is a public company based in the United States, focusing on developing treatments for mental health conditions. The company has a market capitalization of approximately $9.29 million. Vistagen is dedicated to advancing its innovative therapies to address unmet needs in the mental health space.
Latest news from Vistagen Therapeutics, Inc.
Vistagen to Present at Psych Congress 2026
September 10, 2026
Vistagen Reports Fiscal Year 2027 First Quarter Financial Results and Corporate Update
August 14, 2026
Vistagen Announces Topline Results for Repeat Dose Study of Fasedienol for Acute Treatment of Social Anxiety Disorder
August 6, 2026
SRX Global Acquires Stake in Vistagen Therapeutics (NASDAQ: VTGN)
August 4, 2026
Vistagen Appoints Douglas J. Williamson to its Board of Directors
July 31, 2026
Vistagen Therapeutics, Inc. earnings calls
Vistagen Therapeutics, Inc. (VTGN) Q3 2026 Earnings Call
February 12, 2026 · Replay with transcript and chapters
Vistagen Therapeutics, Inc. (VTGN) Q2 2026 Earnings Call
November 13, 2025 · Replay with transcript and chapters
Vistagen Therapeutics, Inc. (VTGN) Q1 2026 Earnings Call
August 7, 2025 · Replay with transcript and chapters
Vistagen Therapeutics, Inc. (VTGN) Q4 2025 Earnings Call
June 17, 2025 · Replay with transcript and chapters
Vistagen Therapeutics, Inc. (VTGN) Q3 2025 Earnings Call
February 13, 2025 · Replay with transcript and chapters
Vistagen Therapeutics, Inc. (VTGN) Q2 2025 Earnings Call
November 7, 2024 · Replay with transcript and chapters
Research Vistagen Therapeutics, Inc.
Vistagen Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for VTGN:NASDAQ.
Vistagen Therapeutics, Inc. company profile
View the public company page for Vistagen Therapeutics, Inc. on 6ix.
Vistagen Therapeutics, Inc. news
Read company news and market updates connected to Vistagen Therapeutics, Inc..
Vistagen Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Vistagen Therapeutics, Inc..
Alternate listings
VTGN:BOATS
US · USD
Alternate listing for Vistagen Therapeutics, Inc.; the primary context on this page is VTGN:NASDAQ.
VTGN:BMV
MX · MXN
Alternate listing for Vistagen Therapeutics, Inc.; the primary context on this page is VTGN:NASDAQ.
VTGN:BIVA
MX · MXN
Alternate listing for Vistagen Therapeutics, Inc.; the primary context on this page is VTGN:NASDAQ.